Platelet-activating factor receptor gene polymorphism in Japanese patients with multiple sclerosis

被引:10
|
作者
Osoegawa, M
Miyagishi, R
Ochi, H
Nakamura, I
Niino, M
Kikuchi, S
Murai, H
Fukazawa, T
Minohara, M
Tashiro, K
Kira, J [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 8128582, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan
[3] Hokuyukai Neurol Hosp, Sapporo, Hokkaido, Japan
关键词
polymorphism; platelet-activating factor receptor; multiple sclerosis; Japanese; missense mutation;
D O I
10.1016/j.jneuroim.2004.12.014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We evaluated the association of the platelet-activating factor receptor (PAFR) gene polymorphism (A224D) with the susceptibility and severity of multiple sclerosis (MS) in a Japanese population. DNA was collected from 162 Japanese patients with clinically definite 'conventional' MS (MS) and 245 healthy controls. The missense mutation A224D that impairs PAF-PAFR signaling was determined by polymerase chain reaction restriction fragment length polymorphism. The frequency of the AD/DD genotypes was significantly higher in MS patients (21.0%) than in healthy controls (13.5%) (p=0.045; odds ratio (OR), 1.71; 95% confidence interval (0), 1.01-2.89). Moreover, the frequency of D allele in MS patients (11.7%) was also significantly higher than those in healthy controls (6.9%) (p=0.019; OR, 1.78; 95% Cl, 1.10-2.89). These findings suggest that the PAFR gene missense mutation has a relation to the susceptibility for MS. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:195 / 198
页数:4
相关论文
共 50 条
  • [21] PLATELET-ACTIVATING FACTOR
    WYKLE, RL
    OFLAHERTY, JT
    THOMAS, MJ
    METHODS IN ENZYMOLOGY, 1988, 163 : 44 - 54
  • [22] PLATELET-ACTIVATING FACTOR
    MARTIN, J
    LANCET, 1988, 2 (8626-7): : 1486 - 1486
  • [23] PLATELET-ACTIVATING FACTOR
    CUSACK, NJ
    NATURE, 1980, 285 (5762) : 193 - 193
  • [24] Platelet-activating factor
    Owen, John S.
    Thomas, Michael J.
    Wykle, Robert L.
    LIPIDOMICS AND BIOACTIVE LIPIDS: LIPIDS AND CELL SIGNALING, 2007, 434 : 105 - 116
  • [25] PLATELET-ACTIVATING FACTOR
    PINCKARD, RN
    HOSPITAL PRACTICE, 1983, 18 (11): : 67 - 76
  • [26] PLATELET-ACTIVATING FACTOR
    VALONE, FH
    WESTERN JOURNAL OF MEDICINE, 1989, 150 (03): : 334 - 334
  • [27] Comparison of the coding sequence of the platelet-activating factor receptor gene in three species
    Yang, WS
    Diehl, JR
    Roudebush, WE
    DNA SEQUENCE, 2001, 12 (04): : 239 - 251
  • [28] Role of platelet-activating factor acetylhydrolase gene mutation in Japanese childhood IgA nephropathy
    Tanaka, R
    Iijima, K
    Xu, H
    Inoue, Y
    Murakami, R
    Shirakawa, T
    Nishiyama, K
    Miwa, M
    Shiozawa, S
    Nakamura, H
    Yoshikawa, N
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (02) : 289 - 295
  • [29] Platelet-activating factor receptor - Gene structure and tissue-specific regulation
    Shimizu, T
    Mutoh, H
    Kato, S
    PLATELET-ACTIVATING FACTOR AND RELATED LIPID MEDIATORS 2: ROLES IN HEALTH AND DISEASE, 1996, 416 : 79 - 84
  • [30] Antiobese function of platelet-activating factor: increased adiposity in platelet-activating factor receptor- deficient mice with age
    Sugatani, Junko
    Sadamitsu, Satoshi
    Yamaguchi, Masahiko
    Yamazaki, Yasuhiro
    Higa, Ryoko
    Hattori, Yoshiki
    Uchida, Takahiro
    Ikari, Akira
    Sugiyama, Wataru
    Watanabe, Tatsuo
    Ishii, Satoshi
    Miwa, Masao
    Shimizu, Takao
    FASEB JOURNAL, 2014, 28 (01): : 440 - 452